Podocalixina (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Podocalixina" in Galician language version.

refsWebsite

Global rank Galician rank

13nih.gov

4^th place

6^th place

12doi.org

2^nd place

7^th place

2archive.org

6^th place

8^th place

2harvard.edu

18^th place

38^th place

1zenodo.org

621^st place

1,077^th place

1handle.net

102^nd place

163^rd place

archive.org

Gartner, LP; Hiatt, Strum (2007). Cell Biology and Histology. Lippincott Williams and Wilkins. ISBN 978-0-7817-8577-8.
Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004). "Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression". Cancer Res 64 (15): 5068–73. PMID 15289306. doi:10.1158/0008-5472.CAN-04-0240. hdl:1807.1/116.

doi.org

dx.doi.org

Nielsen JS, McNagny KM (2008). "Novel functions of the CD34 family". Journal of Cell Science 121 (Pt 22): 3682–3692. PMID 18987355. doi:10.1242/jcs.037507.
Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM (2001). "Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin". J Exp Med 194 (1): 13–27. PMC 2193439. PMID 11435469. doi:10.1084/jem.194.1.13.
Nielsen JS, McNagny KM (2009). "The role of podocalyxin in health and disease". J Am Soc Nephrol 20 (10): 1669–76. PMID 19578008. doi:10.1681/ASN.2008070782.
Cait, Jessica; Hughes, Michael R.; Zeglinski, Matthew R.; Chan, Allen W.; Osterhof, Sabrina; Scott, R. Wilder; Hernaez, Diana Canals; Cait, Alissa; Vogl, A. Wayne; Bernatchez, Pascal; Underhill, T. Michael; Granville, David J.; Murphy, Timothy H.; Roskelley, Calvin D.; McNagny, Kelly M. (5 de marzo de 2019). "Podocalyxin is required for maintaining blood–brain barrier function during acute inflammation". Proceedings of the National Academy of Sciences 116 (10): 4518–4527. PMC 6410846. PMID 30787191. doi:10.1073/pnas.1814766116.
Strilić, Boris; Kučera, Tomáš; Eglinger, Jan; Hughes, Michael R.; McNagny, Kelly M.; Tsukita, Sachiko; Dejana, Elisabetta; Ferrara, Napoleone; Lammert, Eckhard (outubro de 2009). "The Molecular Basis of Vascular Lumen Formation in the Developing Mouse Aorta". Developmental Cell 17 (4): 505–515. PMID 19853564. doi:10.1016/j.devcel.2009.08.011.
Debruin EJ, Hughes MR, et al. (2014). "Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion". PLOS ONE 9 (10): e108881. Bibcode:2014PLoSO...9j8881D. PMC 4193771. PMID 25303643. doi:10.1371/journal.pone.0108881.
Snyder, Kimberly A; Hughes, Michael R; Hedberg, Bradley; Brandon, Jill; Hernaez, Diana Canals; Bergqvist, Peter; Cruz, Frederic; Po, Kelvin; Graves, Marcia L; Turvey, Michelle E; Nielsen, Julie S; Wilkins, John A; McColl, Shaun R; Babcook, John S; Roskelley, Calvin D; McNagny, Kelly M (27 de marzo de 2015). "Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy". Breast Cancer Research 17 (1): 46. PMC 4423095. PMID 25887862. doi:10.1186/s13058-015-0562-7.
Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004). "Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression". Cancer Res 64 (15): 5068–73. PMID 15289306. doi:10.1158/0008-5472.CAN-04-0240. hdl:1807.1/116.
Thomas SN, Schnaar RL, Konstantopoulos K (marzo de 2009). "Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells". Am J Physiol Cell Physiol 296 (3): C505–13. PMC 2660269. PMID 19118161. doi:10.1152/ajpcell.00472.2008.
Konstantopoulos K, Thomas SN (2009). "Cancer cells in transit: the vascular interactions of tumor cells". Annu Rev Biomed Eng 11: 177–202. PMID 19413512. doi:10.1146/annurev-bioeng-061008-124949.
Thomas SN, Tong Z, Stebe KJ, Konstantopoulos K (2009). "Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics". Biorheology 46 (3): 207–25. PMID 19581728. doi:10.3233/BIR-2009-0534.
Nielsen JS, Graves ML, Chelliah S, Vogl AW, Roskelley CD, McNagny KM (2007). "The CD34-related molecule podocalyxin is a potent inducer of microvillus formation". PLOS ONE 2 (2): e237. Bibcode:2007PLoSO...2..237N. PMC 1796660. PMID 17311105. doi:10.1371/journal.pone.0000237.

handle.net

hdl.handle.net

Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004). "Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression". Cancer Res 64 (15): 5068–73. PMID 15289306. doi:10.1158/0008-5472.CAN-04-0240. hdl:1807.1/116.

harvard.edu

adsabs.harvard.edu

Debruin EJ, Hughes MR, et al. (2014). "Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion". PLOS ONE 9 (10): e108881. Bibcode:2014PLoSO...9j8881D. PMC 4193771. PMID 25303643. doi:10.1371/journal.pone.0108881.
Nielsen JS, Graves ML, Chelliah S, Vogl AW, Roskelley CD, McNagny KM (2007). "The CD34-related molecule podocalyxin is a potent inducer of microvillus formation". PLOS ONE 2 (2): e237. Bibcode:2007PLoSO...2..237N. PMC 1796660. PMID 17311105. doi:10.1371/journal.pone.0000237.

nih.gov

ncbi.nlm.nih.gov

Omim - Podocalyxin-Like; Podxl
Nielsen JS, McNagny KM (2008). "Novel functions of the CD34 family". Journal of Cell Science 121 (Pt 22): 3682–3692. PMID 18987355. doi:10.1242/jcs.037507.
Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM (2001). "Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin". J Exp Med 194 (1): 13–27. PMC 2193439. PMID 11435469. doi:10.1084/jem.194.1.13.
Nielsen JS, McNagny KM (2009). "The role of podocalyxin in health and disease". J Am Soc Nephrol 20 (10): 1669–76. PMID 19578008. doi:10.1681/ASN.2008070782.
Cait, Jessica; Hughes, Michael R.; Zeglinski, Matthew R.; Chan, Allen W.; Osterhof, Sabrina; Scott, R. Wilder; Hernaez, Diana Canals; Cait, Alissa; Vogl, A. Wayne; Bernatchez, Pascal; Underhill, T. Michael; Granville, David J.; Murphy, Timothy H.; Roskelley, Calvin D.; McNagny, Kelly M. (5 de marzo de 2019). "Podocalyxin is required for maintaining blood–brain barrier function during acute inflammation". Proceedings of the National Academy of Sciences 116 (10): 4518–4527. PMC 6410846. PMID 30787191. doi:10.1073/pnas.1814766116.
Strilić, Boris; Kučera, Tomáš; Eglinger, Jan; Hughes, Michael R.; McNagny, Kelly M.; Tsukita, Sachiko; Dejana, Elisabetta; Ferrara, Napoleone; Lammert, Eckhard (outubro de 2009). "The Molecular Basis of Vascular Lumen Formation in the Developing Mouse Aorta". Developmental Cell 17 (4): 505–515. PMID 19853564. doi:10.1016/j.devcel.2009.08.011.
Debruin EJ, Hughes MR, et al. (2014). "Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion". PLOS ONE 9 (10): e108881. Bibcode:2014PLoSO...9j8881D. PMC 4193771. PMID 25303643. doi:10.1371/journal.pone.0108881.
Snyder, Kimberly A; Hughes, Michael R; Hedberg, Bradley; Brandon, Jill; Hernaez, Diana Canals; Bergqvist, Peter; Cruz, Frederic; Po, Kelvin; Graves, Marcia L; Turvey, Michelle E; Nielsen, Julie S; Wilkins, John A; McColl, Shaun R; Babcook, John S; Roskelley, Calvin D; McNagny, Kelly M (27 de marzo de 2015). "Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy". Breast Cancer Research 17 (1): 46. PMC 4423095. PMID 25887862. doi:10.1186/s13058-015-0562-7.
Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004). "Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression". Cancer Res 64 (15): 5068–73. PMID 15289306. doi:10.1158/0008-5472.CAN-04-0240. hdl:1807.1/116.
Thomas SN, Schnaar RL, Konstantopoulos K (marzo de 2009). "Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells". Am J Physiol Cell Physiol 296 (3): C505–13. PMC 2660269. PMID 19118161. doi:10.1152/ajpcell.00472.2008.
Konstantopoulos K, Thomas SN (2009). "Cancer cells in transit: the vascular interactions of tumor cells". Annu Rev Biomed Eng 11: 177–202. PMID 19413512. doi:10.1146/annurev-bioeng-061008-124949.
Thomas SN, Tong Z, Stebe KJ, Konstantopoulos K (2009). "Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics". Biorheology 46 (3): 207–25. PMID 19581728. doi:10.3233/BIR-2009-0534.
Nielsen JS, Graves ML, Chelliah S, Vogl AW, Roskelley CD, McNagny KM (2007). "The CD34-related molecule podocalyxin is a potent inducer of microvillus formation". PLOS ONE 2 (2): e237. Bibcode:2007PLoSO...2..237N. PMC 1796660. PMID 17311105. doi:10.1371/journal.pone.0000237.

zenodo.org

Nielsen JS, McNagny KM (2009). "The role of podocalyxin in health and disease". J Am Soc Nephrol 20 (10): 1669–76. PMID 19578008. doi:10.1681/ASN.2008070782.